Multiple mechanisms of Rottlerin toxicity in A375 melanoma cells

Area of Science:

• Oncology
• Molecular Biology
• Cell Biology

Background:

• Rottlerin demonstrates variable cytotoxic effects on cancer cells, inducing apoptosis, autophagy, or cellular atrophy.
• Previous research indicates rottlerin's effects are dependent on the cancer cell's genetic and biochemical background.

Purpose of the Study:

• To investigate the cytotoxic effects and underlying mechanisms of rottlerin in human amelanotic A375 melanoma cells.
• To elucidate rottlerin's impact on cell proliferation, apoptosis, and protein homeostasis in this specific melanoma cell line.

Main Methods:

• Treatment of A375 melanoma cells with rottlerin over varying time periods and doses.
• Analysis of cell proliferation, apoptosis induction, and protein expression.
• Investigation of intrinsic and extrinsic apoptotic pathways, endoplasmic reticulum (ER) stress, and translational regulation.

Main Results:

• Rottlerin significantly inhibited A375 melanoma cell proliferation in a time- and dose-dependent manner, associated with cyclin D1 downregulation.
• Apoptosis was induced as early as 18 hours post-treatment, mediated by both intrinsic and extrinsic pathways.
• Downregulation of antiapoptotic B-cell lymphoma 2 (Bcl-2) protein was observed, impacting mitochondrial and ER membrane stability.
• Rottlerin activated ER stress and the eukaryotic initiation factor 2 alpha (eIF2α) axis, leading to translational shutoff and altered proteostasis.

Conclusions:

• Rottlerin exhibits potent cytotoxic properties against amelanotic A375 melanoma cells, including growth arrest, apoptosis induction, and translation inhibition.
• The drug triggers apoptosis via intrinsic and extrinsic pathways, partly through Bcl-2 downregulation and ER stress activation.
• Disruption of proteostasis by rottlerin contributes to cell death, even in the presence of apoptosis inhibitors, highlighting its novel cytotoxic mechanisms.